Healthy Convergence

By Ashish Singh, Chris Zook, Norbert Hueltenschmidt, IN VIVO 7/1/2004

• Feature Articles
• Word Count: 4336
• Art # 2004800145

Executive Summary

IN VIVO -- Some health care firms have managed to work around the industry's well-documented growth constraints by pursuing a strategy of convergence--finding new combinations of formerly distinct market segments for pharmaceuticals, devices, and diagnostics. The authors, at Bain & Company, outline the considerations that drive the evaluation of and set the stage for convergence opportunities. Companies can use them to capitalize on an array of opportunities throughout the commercialization continuum and develop a response to potential threats from the outside.

For $125, purchase this 4336-word article as a PDF, and receive immediate delivery via email. View a complete sample article.
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.

100% Satisfaction Guarantee